Jon S Odorico, MD


  • Section of Kidney and Pancreas Surgery
  • Division of Transplantation
(608) 263-0388

Clinical Science Center
600 Highland Avenue
Madison WI 53792


  • MD, New York University, School of Medicine, New York, NY
  • Residency, General Surgery, Hospital of the University of Pennsylvania, Philadelphia, PA
  • Postdoctoral Research Fellow, Harrison Department of Surgical Research, Hospital of the University of Pennsylvania, Philadelphia, PA
  • Fellow, Transplant Surgery, University of Wisconsin Hospital and Clinics, Madison, WI

Clinical Specialties

Dr. Odorico is certified by the American Board of Surgery. He specializes in pancreatic, islet cell, and multi-organ transplants.

Dr. Odorico provides a wide range of services including Kidney Transplant, Pancreas Transplant.

Research Interests

Dr. Odorico’s research focuses on stem cell biology and differentiation, developing novel stem cell-based strategies for treating diabetes, pancreas transplantation, and islet cell transplantation.
Dr. Odorico’s lab

Clinical Trials

Conversion from Immediate Release Tacrolimus to Envarsus XR® in Simultaneous Pancreas-Kidney Recipients: Assessment of functional, safety and quality of life outcomes (CIRTEN SPK)
Study sponsor: University of Wisconsin-Madison
Study funding provided by: Veloxis Pharmaceuticals
Jon S. Odorico, MD, Principal Investigator
10/18/2018 –present

Non Invasive Blood Test to Diagnose Acute Rejection After Pancreas and Kidney Transplantation: Pancreas and Renal Rejection Diagnosis Using Circulating Donor-Derived Cell-free DNA in Peripheral Blood (PANCDx)
Study funding provided by: CareDx
Jon S. Odorico, MD, Sub-Investigator
Subcontract Agreement Amendment under negotiation, we expect to start enrollment in the first quarter of 2020

Recent Publications

  • Indications, Techniques, and Barriers for Pancreas Transplant Biopsy: A Consensus Perspective From a Survey of US Centers.
    Singh N, Lentine KL, Fleetwood VA, Woodside KJ, Odorico J, Axelrod D, Alhamad T, Maher K, Xiao H, Fridell J, Kukla A, Pavlakis M, Shokouh-Amiri HM, Zibari G, Cooper M, Parsons RF
    Transplantation 2024 Mar 12;
    [PubMed ID: 38467588]

  • Incidence, Risk Factors, and Outcomes of Posttransplant Erythrocytosis Among Simultaneous Pancreas-Kidney Transplant Recipients.
    Gibes ML, Astor BC, Odorico J, Mandelbrot D, Parajuli S
    Transplant Direct 2024 Apr; 10(4): e1607
    [PubMed ID: 38464426]

  • Resource Use and Financial Impact of Oral Step-Down Therapy for Resistant Cytomegalovirus in Solid Organ Transplant Recipients.
    Kleiboeker H, Descourouez JL, Schulz LT, Mandelbrot DA, Odorico JS, Saddler CM, Smith JA, Jorgenson MR
    Transplant Proc 2024 Mar; 56(2): 434-439
    [PubMed ID: 38355369]

  • Twelve Thousand Kidney Transplants Over More Than 55 Y: A Single-center Experience.
    Parajuli S, Garonzik-Wang J, Astor BC, Aziz F, Garg N, Welch B, Odorico J, Mezrich J, Kaufman D, Foley DP, Mandelbrot D
    Transplant Direct 2024 Feb; 10(2): e1575
    [PubMed ID: 38264296]

  • Impact of pancreas transplantation alone on kidney function: A multicenter clinical cohort study.
    Kaur RJ, Mujtahedi SS, Fridell JA, Benavides X, Smith B, Larson TS, Rizvi SR, Kukla A, Dean P, Kudva YC, Odorico J, Stegall M
    Clin Transplant 2024 Jan; 38(1): e15212
    [PubMed ID: 38041451]

All Publications on PubMed